A
Anat Mirelman
Researcher at Tel Aviv Sourasky Medical Center
Publications - 246
Citations - 12440
Anat Mirelman is an academic researcher from Tel Aviv Sourasky Medical Center. The author has contributed to research in topics: Medicine & Gait (human). The author has an hindex of 47, co-authored 208 publications receiving 9246 citations. Previous affiliations of Anat Mirelman include Harvard University & Ben-Gurion University of the Negev.
Papers
More filters
Journal ArticleDOI
Distinguishing Dementia With Lewy Bodies From Alzheimer Disease: What is the Influence of the GBA Genotype in Ashkenazi Jews?
Noa Bregman,Gitit Kavé,Anat Mirelman,Avner Thaler,Mali Gana Weisz,Anat Bar-Shira,Avi Orr-Urtreger,Avi Orr-Urtreger,Nir Giladi,Tamara Shiner +9 more
TL;DR: It is suggested that verbal fluency tasks could serve as a possible clinical marker to subtype patients with DLB, with phonemic fluency being a marker for GBA-associated DLB.
Journal ArticleDOI
Impaired Inhibitory Control During Walking in Parkinson's Disease Patients: An EEG Study.
Ronen Sosnik,Shani Danziger-Schragenheim,Shani Danziger-Schragenheim,Daniel Possti,Firas Fahoum,Firas Fahoum,Nir Giladi,Jeffrey M. Hausdorff,Jeffrey M. Hausdorff,Jeffrey M. Hausdorff,Anat Mirelman,Anat Mirelman,Inbal Maidan,Inbal Maidan +13 more
TL;DR: In this paper, the effect of gait on automatic and cognitive inhibitory control phases in Parkinson's disease patients and associated changes in neural activity and compared them with young and older adults was explored.
Journal ArticleDOI
New virtual reality protocol for gait training in patients with multiple sclerosis
E. Aiello,A. Peruzzi,P. Fadda,A. Serra,D. Sidore,D. Solinas,S. Sotgiu,C. Varone,U. Della Croce,Anat Mirelman +9 more
TL;DR: The results show an improvement of gait and balance with a decrease of fall risk confirming the relevance of rehabilitation in MS patients, and the results are very encouraging to those who hope to use VR with MS patients as a form of therapy.
Journal ArticleDOI
C9orf72-G4C2 Intermediate Repeats and Parkinson’s Disease; A Data-Driven Hypothesis
Hila Kobo,Orly Goldstein,Mali Gana-Weisz,Anat Bar-Shira,Tanya Gurevich,Avner Thaler,Anat Mirelman,Nir Giladi,Avi Orr-Urtreger +8 more
TL;DR: In this paper, the authors investigated the potential involvement of C9orf72-G4C2 repeat expansions in Parkinson's disease and suggested a model in which intermediate repeats are a risk factor for PD in non-carriers, driven not only by the number of repeats but also by the variants within the risk-haplotype.
Journal ArticleDOI
Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease
Dafna Ben Bashat,Avner Thaler,Hedva Lerman Shacham,Einat Even-Sapir,R. Matthew Hutchison,Karleyton C. Evans,Avi Orr‐Urterger,Jesse M. Cedarbaum,Amgad Droby,Nir Giladi,Anat Mirelman,Moran Artzi +11 more
TL;DR: In this paper , the sensitivity of neuromelanin-MRI and T2* with radiomics analysis for detecting Parkinson's disease, identifying individuals at risk, and evaluating genotype-related differences was assessed.